BridgeBio Pharma, Inc. Common Stock
$66.32
USD
Last updated on --.
24h volume2.23M
24h highest69.0250 USD
24h lowest66.1580 USD
24h Price movement+0.09%
BBIO recent prices
24 Hours
+0.09%+$0.06
30 days
-3.27%-$2.240
60 days
-10.92%-$8.130
90 days
+1.25%+$0.82
Key data
Previous close66.2600 USD
Market cap12.98B USD
Volume2.23M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-3.6800 USD
Net income (FY)-729.89M USD
Revenue (FY)579.96M USD
Last report dateMay 7, 2026
About BridgeBio Pharma, Inc. Common Stock
HeadquartersPALO ALTO
Employees (FY)839.00
Revenue per employee (FY)691.25K USD
Net income per employee (FY)-869.95K USD
Listed onNasdaq
BBIO conversion tables
 |  |
|---|---|
| 0.5 BBIO | 33.16 USD |
| 1 BBIO | 66.32 USD |
| 5 BBIO | 331.6 USD |
| 10 BBIO | 663.2 USD |
| |
|---|---|
| 0.5 USD | 0.0075392 BBIO |
| 1 USD | 0.015078 BBIO |
| 5 USD | 0.075392 BBIO |
| 10 USD | 0.15078 BBIO |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
BBIO is trading at $66.32, +0.09% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BBIO stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BBIO is currently trading at $66.32, +0.09% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BBIO price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BBIO's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BBIO; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BBIO's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
BridgeBio Pharma, Inc. Common Stock's market cap is currently 12.98B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.23M
24h highest69.0250 USD
24h lowest66.1580 USD
24h Price movement+0.09%
Start trade with BBIO Perpetual
Sign up to trade